AVITA Medical Inc (NASDAQ: RCEL) kicked off on Friday, down -4.48% from the previous trading day, before settling in for the closing price of $5.80. Over the past 52 weeks, RCEL has traded in a range of $5.46-$14.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 63.43% over the past five years. While this was happening, its average annual earnings per share was recorded 12.10%. With a float of $24.59 million, this company’s outstanding shares have now reached $26.43 million.
Let’s look at the performance matrix of the company that is accounted for 260 employees. In terms of profitability, gross margin is 85.85%, operating margin of -88.08%, and the pretax margin is -96.17%.
AVITA Medical Inc (RCEL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of AVITA Medical Inc is 1.01%, while institutional ownership is 28.51%. The most recent insider transaction that took place on Mar 06 ’25, was worth 91,300. In this transaction Director of this company bought 11,000 shares at a rate of $8.30, taking the stock ownership to the 56,749 shares. Before that another transaction happened on Feb 20 ’25, when Company’s Director bought 10,000 for $10.09, making the entire transaction worth $100,900. This insider now owns 45,749 shares in total.
AVITA Medical Inc (RCEL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.10% per share during the next fiscal year.
AVITA Medical Inc (NASDAQ: RCEL) Trading Performance Indicators
Take a look at AVITA Medical Inc’s (RCEL) current performance indicators. Last quarter, stock had a quick ratio of 1.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of AVITA Medical Inc (RCEL)
AVITA Medical Inc (NASDAQ: RCEL) saw its 5-day average volume 0.34 million, a positive change from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 40.74%. Additionally, its Average True Range was 0.45.
During the past 100 days, AVITA Medical Inc’s (RCEL) raw stochastic average was set at 3.87%, which indicates a significant decrease from 20.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.80% in the past 14 days, which was lower than the 78.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.66, while its 200-day Moving Average is $9.75. Nevertheless, the first resistance level for the watch stands at $5.74 in the near term. At $5.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.15. If the price goes on to break the first support level at $5.32, it is likely to go to the next support level at $5.11. Assuming the price breaks the second support level, the third support level stands at $4.91.
AVITA Medical Inc (NASDAQ: RCEL) Key Stats
The company with the Market Capitalisation of 137.61 million has total of 26,435K Shares Outstanding. Its annual sales at the moment are 64,250 K in contrast with the sum of -61,850 K annual income. Company’s last quarter sales were recorded 18,510 K and last quarter income was -13,860 K.
